Weng G - Search Results

1

Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.

Weng G, Zhang Y, Yu G, Luo T, Yu S, Xu N, Sun Z, Lin D, Deng L, Liang X, Xiao J, Zhang H, Guo Z, Shao R, Du X, Jin H, Liu Q. Weng G, et al. J Intern Med. 2023 Mar;293(3):329-339. doi: 10.1111/joim.13581. Epub 2022 Nov 3. J Intern Med. 2023. PMID: 36284445

2

Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.

Ye Y, Xu X, Zhang M, Qiu D, Bai X, Wang J, Weng G, Zhou R, Guo Z, He H, Yi W, He X, Guo K. Ye Y, et al. Among authors: weng g. Leuk Lymphoma. 2015;56(11):3159-67. doi: 10.3109/10428194.2015.1011155. Epub 2015 Jun 19. Leuk Lymphoma. 2015. PMID: 25739941

3

Haploidentical donor stem cell transplantation had a lower incidence of bronchiolitis obliterans syndrome compared with HLA-matched sibling donor transplantation in patients with hematologic malignancies: Benefit from ATG?

Weng G, Fan Z, Xue H, Huang F, Xu N, Jin H, Yu S, Ye Z, Fan J, Xuan L, Liu Q. Weng G, et al. Front Immunol. 2022 Oct 27;13:1036403. doi: 10.3389/fimmu.2022.1036403. eCollection 2022. Front Immunol. 2022. PMID: 36389692 Free PMC article.

4

Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement.

Ding W, Weng G, Wang Z, Guo Y, Wang M, Shen H, Chen S, Du X, Wen L. Ding W, et al. Among authors: weng g. Front Oncol. 2023 Jan 9;12:1028651. doi: 10.3389/fonc.2022.1028651. eCollection 2022. Front Oncol. 2023. PMID: 36713535 Free PMC article.

5

Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study.

Weng G, Huang J, He X, Xue T, Yang L, Zhang Y, Yu G, Sun Z, Lin D, Deng L, Liang X, Xiao J, Zhang H, Guo Z, Jin H, Liu Q, Du X. Weng G, et al. Ann Hematol. 2023 Dec;102(12):3369-3381. doi: 10.1007/s00277-023-05452-7. Epub 2023 Sep 18. Ann Hematol. 2023. PMID: 37723307

6

[Efficacy of Venetoclax Plus Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia Patients with FLT3-ITD Mutation].

Weng GY, You WW, Liu HX, Cai Y, DU X. Weng GY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Oct;31(5):1333-1339. doi: 10.19746/j.cnki.issn.1009-2137.2023.05.013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 37846681 Chinese.

7

Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy.

Weng G, Huang J, An N, Zhang Y, Yu G, Sun Z, Lin D, Deng L, Liang X, Xiao J, Zhang H, Guo Z, He X, Jin H, Liu Q, Du X. Weng G, et al. Cancer Med. 2024 Jan;13(2):e6885. doi: 10.1002/cam4.6885. Cancer Med. 2024. PMID: 38334500 Free PMC article.

8

Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia.

Yin Z, Yao Z, Chen D, Zhang Y, Weng G, Du X, Lin D, Xiao J, Sun Z, Zhang H, Liang X, Guo Z, Zhao W, Xuan L, Jiang X, Shi P, Liu Q, Ping B, Yu G. Yin Z, et al. Among authors: weng g. J Cancer Res Clin Oncol. 2024 Jul 6;150(7):336. doi: 10.1007/s00432-024-05861-9. J Cancer Res Clin Oncol. 2024. PMID: 38969948 Free PMC article.

9

Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study.

Yu G, Zhang Y, Yu S, Yin Z, Weng G, Xu N, Du X, Lin D, Xiao J, Sun Z, Zhang H, Liang X, Guo Z, Zhao W, Dai M, Fan Z, Xuan L, Liu H, Xu D, Ye J, Jiang X, Shi P, Jin H, Liu Q. Yu G, et al. Among authors: weng g. Clin Cancer Res. 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-1332. Online ahead of print. Clin Cancer Res. 2024. PMID: 39531539

10

Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells.

Zeng Y, Weng G, Fan J, Li Z, Wu J, Li Y, Zheng R, Xia P, Guo K. Zeng Y, et al. Among authors: weng g. Oncol Rep. 2016 Sep;36(3):1233-42. doi: 10.3892/or.2016.4944. Epub 2016 Jul 15. Oncol Rep. 2016. PMID: 27430728 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters